Werewolf Therapeutics, Inc. (HOWL) vs Precipio, Inc. (PRPO)
A side-by-side comparison of Werewolf Therapeutics, Inc. and Precipio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
HOWL
Werewolf Therapeutics, Inc.
$0.93HealthcareDelayed quote: Oct 6, 2026, 12:20 PM EDT
PRPO
Precipio, Inc.
$23.89HealthcareDelayed quote: Oct 6, 2026, 12:15 PM EDT
Total return — HOWL vs PRPO
growth of $100 · dividends reinvested · last 5yHOWL -94.2% (-43.5%/yr)PRPO -36.5% (-8.7%/yr)PRPO compounded faster over this window
Log scale — wide-divergence pair
HOWL PRPO
HOWL vs PRPO: by the numbers
- •HOWL is the larger company ($45M vs $43M market cap).
- •Both run net losses; PRPO's is the smaller (-4.42% vs -164.82% net margin).
Metrics side by side
Valuation
| Metric | HOWL | PRPO |
|---|---|---|
| P/S ratio | 2.15 | 1.55 |
| P/B ratio | 2.77 | 2.89 |
| FCF yield | N/A | 1.85% |
Profitability
| Metric | HOWL | PRPO |
|---|---|---|
| Gross margin | 0.00% | 43.69% |
| Operating margin | 0.00% | -5.63% |
| Net margin | -164.82% | -4.42% |
| ROE | -212.45% | -8.23% |
| ROIC | -156.97% | -8.43% |
Growth (annualized)
| Metric | HOWL | PRPO |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 28.84% |
| Total return CAGR (5Y) | -44.27% | -14.46% |
Frequently asked
- How have HOWL and PRPO total returns compared?
- Over the past 5 years, HOWL delivered -44.27% and PRPO delivered -14.46% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Werewolf Therapeutics ROEPrecipio ROEWerewolf Therapeutics operating marginPrecipio operating marginWerewolf Therapeutics revenue growthPrecipio revenue growthWerewolf Therapeutics free cash flowPrecipio free cash flow
Werewolf Therapeutics & Precipio appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.